Nevertheless, LCN2 treatment promoted insulin resistance in H4IIe hepatocytes (250 ng/mL) [117] and human adipose tissue (100 ng/mL) [118], and LCN2 knockdown in 3T3-L1 adipocytes increased insulin sensitivity [117]. The gene discussed is LCN2; the disease is Insulin resistance.